How to make PROMs work: qualitative insights from leaders at United States hospitals with successful PROMs programs.

"Declarations Competing interestsDr. Mjåset declares a one-year stipend to do healthcare policy research (2019/2020) at the Harvard TH Chan School of Public Health in relation to this work as well as stocks in Ledidi AS (no payments received). Dr. Pusic is a co-developer of the QPROMS which are owned by Memorial Sloan-Kettering Cancer Center. Dr. Pusic receives a portion of licensing fees (royalty payments) when QPROMS are used in industry-sponsored clinical trials. The remaining authors declare no competing interests. Ethical approvalApproval for the study was obtained by the Harvard T.H. Chan School of Public Health IRB (IRB20-0090). Consent to participateVerbal consent was obtained at interview onset. Consent to publishNot applicable. Competing interests Dr. Mjåset declares a one-year stipend to do healthcare policy research (2019/2020) at the Harvard TH Chan School of Public Health in relation to this work as well as stocks in Ledidi AS (no payments received). Dr. Pusic is a co-developer of the QPROMS which are owned by Memorial Sloan-Kettering Cancer Center. Dr. Pusic receives a portion of licensing fees (royalty payments) when QPROMS are used in industry-sponsored clinical trials. The remaining authors declare no competing interests."

"Funding Dr. Mjåset received a one-year stipend to do healthcare policy research (2019/2020) at the Harvard TH Chan School of Public Health. Harvard T.H. Chan School of Public Health."